• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session

    10/19/22 12:30:03 PM ET
    $ABT
    $ASML
    $AYLA
    $CABA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Machinery/Components
    Technology
    Get the next $ABT alert in real time by email

    Gainers

    • SenesTech, Inc. (NASDAQ:SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) rose 66% to $0.4075. Scopus Biopharma completed recapitalization designed to enhance shareholder value.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) gained 61.6% to $0.75 after the company announced its oral broad-acting antiviral, Opaganib, was granted a new COVID-19 treatment patent.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) jumped 40% to $0.1401. The company announced it paused its REM-001 program to conserve funds to support its VAL-083 international registrational study.
    • HV Bancorp, Inc. (NASDAQ:HVBC) climbed 29% to $25.87. Citizens Financial Services and HV Bancorp signed definitive merger agreement for $67.4 million.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) gained 24.3% to $0.4000.
    • LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) shares gained 22.3% to $10.47 after the company announced stockholders approved the previously-announced business combination with SeaStar Medical.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) surged 19% to $1.18. Cabaletta Bio CEO Steven Nichtberger reported purchase of 141,873 shares at an average price of $0.99 per share in Form 4 Filing on Tuesday.
    • SOBR Safe, Inc. (NASDAQ:SOBR) shares gained 17.6% to $3.1270 after the company announced it secured a large industrial customer and validation of its sales strategy.
    • Momentive Global Inc. (NASDAQ:MNTV) surged 16% to $7.54 following a Bloomberg report suggesting the company is considering a sale after receiving takeover interest.
    • SaverOne 2014 Ltd (NASDAQ:SVRE) jumped 16% to $1.67. SaverOne signed a memorandum of understanding with leading truck manufacturer, Iveco.
    • Gaucho Group Holdings, Inc. (NASDAQ:VINO) gained 16% to $0.3028.
    • Oblong, Inc. (NASDAQ:OBLG) rose 14.5% to $0.5151 after gaining 25% on Tuesday.
    • Netflix, Inc. (NASDAQ:NFLX) rose 14% to $274.64 after the company reported better-than-expected Q3 results and reported global streaming paid net additions of 2.41 million. Global streaming paid memberships grew 4.5% year over year.
    • Zymeworks Inc. (NASDAQ:ZYME) gained 12.8% to $6.34 after the company and Jazz Pharmaceuticals announced an exclusive license agreement to develop and commercialize zanidatamab.
    • Intuitive Surgical, Inc. (NASDAQ:ISRG) shares rose 11.4% to $215.88 as the company reported better-than-expected third-quarter adjusted EPS and sales results.
    • Waterdrop Inc. (NYSE:WDH) gained 8.8% to $1.23.
    • Interactive Brokers Group, Inc. (NASDAQ:IBKR) rose 6.2% to $75.58 following upbeat Q3 earnings.
    • United Airlines Holdings, Inc. (NASDAQ:UAL) rose 5.7% to $39.40 after the company reported better-than-expected Q3 results.
    • ASML Holding N.V. (NASDAQ:ASML) rose 3.2% to $411.76 after reporting upbeat quarterly sales.


    Losers

    • Olaplex Holdings, Inc. (NASDAQ:OLPX) shares tumbled 50.4% to $4.8599 after the company issued Q3 and FY22 sales guidance below analyst estimates.
    • Sientra, Inc. (NASDAQ:SIEN) dipped 27.8% to $0.44 after the company announced a proposed public offering.
    • Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) dropped 23.7% to $0.6950. Advaxis and Ayala Pharmaceuticals entered into merger agreement in all-stock deal.
    • Gelesis Holdings, Inc. (NYSE:GLS) dipped 21.5% to $0.6239.
    • Generac Holdings Inc. (NYSE:GNRC) fell 19.8% to $118.49 after the company reported preliminary Q3 EPS results are lower year over year. The company also lowered its FY22 net sales growth guidance and net income margin.
    • mCloud Technologies Corp. (NASDAQ:MCLD) dropped 19.5% to $0.99.
    • EQRx, Inc. (NASDAQ:EQRX) fell 17.6% to $4.5350.
    • Establishment Labs Holdings Inc. (NASDAQ:ESTA) dropped 16.3% to $47.19. Hindenburg Research issued report on Establishment Labs titled 'A Financially Stretched Silicone Safety Charade.'
    • ProPhase Labs, Inc. (NASDAQ:PRPH) fell 13.8% to $9.36. ProPhase Labs announced collaboration with G42 Healthcare.
    • Horizon Global Corporation (NYSE:HZN) declined 13.6% to $0.6993.
    • EverCommerce Inc. (NASDAQ:EVCM) fell 13.1% to $8.25. Goldman Sachs initiated coverage on EverCommerce with a Sell rating and announced a price target of $8.
    • Repligen Corporation (NASDAQ:RGEN) dropped 12.3% to $181.38.
    • M&T Bank Corporation (NYSE:MTB) fell 12.5% to $165.60 after the company reported worse-than-expected Q3 EPS results.
    • Eqonex Limited (NASDAQ:EQOS) shares fell 11.7% to $0.3109 after jumping 35% on Tuesday.
    • Winnebago Industries, Inc. (NYSE:WGO) dropped 10.8% to $53.64 following Q4 results.
    • Quanergy Systems, Inc. (NYSE:QNGY) fell 10.2% to $1.2659 after dipping 16% on Tuesday. Quanergy Systems recently announced a restructuring plan including an 11% staff reduction.
    • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) fell 9.6% to $0.2421 after gaining around 8% on Tuesday. Kala Pharmaceuticals, during August, posted a Q2 loss of $0.38 per share.
    • The Vita Coco Company, Inc. (NASDAQ:COCO) dropped 9.1% to $10.68.
    • Insmed Incorporated (NASDAQ:INSM) dipped 9% to $20.03. Insmed announced strategic financings totaling $775 million.
    • Carvana Co. (NYSE:CVNA) fell 8.8% to $16.75. Wells Fargo maintained Carvana with an Equal-Weight and lowered the price target from $35 to $30.
    • THOR Industries, Inc. (NYSE:THO) dropped 7.4% to $75.29. Thor Industries Board of Directors recently approved a 5% increase in its quarterly dividend to $0.45 from $0.43.
    • Rubicon Technologies, Inc. (NASDAQ:RBT) shares fell 7.2% to $1.6150 after jumping 58% on Tuesday.
    • Abbott Laboratories (NYSE:ABT) dropped 7.1% to $97.53 despite the company reporting better-than-expected Q3 EPS and sales results and raising guidance. The company's Q3 sales decreased 4.7% year over year.
    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $ASML
    $AYLA
    $CABA

    CompanyDatePrice TargetRatingAnalyst
    Insmed Incorporated
    $INSM
    4/10/2026$200.00Outperform
    Raymond James
    Interactive Brokers Group Inc.
    $IBKR
    4/8/2026$75.00Mkt Perform
    Keefe Bruyette
    Carvana Co.
    $CVNA
    4/6/2026$360.00Buy → Neutral
    BofA Securities
    Netflix Inc.
    $NFLX
    4/6/2026$120.00Neutral → Buy
    Goldman
    Netflix Inc.
    $NFLX
    3/30/2026Mkt Perform
    Citizens
    Insmed Incorporated
    $INSM
    3/30/2026$212.00Equal-Weight → Overweight
    Morgan Stanley
    Netflix Inc.
    $NFLX
    3/24/2026Hold → Buy
    Erste Group
    Generac Holdlings Inc.
    $GNRC
    3/20/2026$222.00Hold
    Jefferies
    More analyst ratings

    $ABT
    $ASML
    $AYLA
    $CABA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Roper Martin

    4 - Vita Coco Company, Inc. (0001482981) (Issuer)

    4/14/26 6:35:59 PM ET
    $COCO
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4 filed by Taira Thomas

    4 - CARVANA CO. (0001690820) (Issuer)

    4/10/26 5:38:33 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form 4 filed by Schayowitz Adam

    4 - Zymeworks Inc. (0001937653) (Issuer)

    4/10/26 4:10:04 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ASML
    $AYLA
    $CABA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on Insmed with a new price target

    Raymond James initiated coverage of Insmed with a rating of Outperform and set a new price target of $200.00

    4/10/26 8:32:03 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Keefe Bruyette resumed coverage on Interactive Brokers with a new price target

    Keefe Bruyette resumed coverage of Interactive Brokers with a rating of Mkt Perform and set a new price target of $75.00

    4/8/26 8:36:42 AM ET
    $IBKR
    Investment Bankers/Brokers/Service
    Finance

    Carvana downgraded by BofA Securities with a new price target

    BofA Securities downgraded Carvana from Buy to Neutral and set a new price target of $360.00

    4/6/26 8:41:44 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $ABT
    $ASML
    $AYLA
    $CABA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ARIKAYCE KIT issued to INSMED INC

    Submission status for INSMED INC's drug ARIKAYCE KIT (SUPPL-13) with active ingredient AMIKACIN SULFATE has changed to 'Approval' on 06/01/2023. Application Category: NDA, Application Number: 207356, Application Classification: Labeling

    6/2/23 4:38:39 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ARIKAYCE KIT issued to INSMED INC

    Submission status for INSMED INC's drug ARIKAYCE KIT (SUPPL-12) with active ingredient AMIKACIN SULFATE has changed to 'Approval' on 02/10/2023. Application Category: NDA, Application Number: 207356, Application Classification: Labeling

    2/13/23 4:39:32 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ASML
    $AYLA
    $CABA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ASML reports €8.8 billion total net sales and €2.8 billion net income in Q1 2026

    ASML reports €8.8 billion total net sales and €2.8 billion net income in Q1 2026ASML now expects 2026 total net sales to be between €36 billion and €40 billion, with a gross margin between 51% and 53% VELDHOVEN, the Netherlands, April 15, 2026 – Today, ASML Holding NV (ASML) has published its 2026 first-quarter results.   Q1 total net sales of €8.8 billion, gross margin of 53.0%, net income of €2.8 billionASML expects Q2 2026 total net sales between €8.4 billion and €9.0 billion, and a gross margin between 51% and 52%ASML now expects 2026 total net sales to be between €36 billion and €40 billion, with a gross margin between 51% and 53% (Figures in millions of euros unless otherwise indicat

    4/15/26 1:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    First Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform

    First two GMP doses of rese-cel manufactured on the Cell Shuttle™ met all release specifications, were delivered on time, and have been infused into patients within Cabaletta Bio's RESET™ clinical trial program. Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced that Cabaletta Bio Inc.'s ("Cabaletta Bio" or "Cabaletta") (NASDAQ:CABA) investigational CAR T cell therapy rese-cel (resecabtagene autoleucel) has been infused into the first two patients using drug product manufactured on Cellares' Cell Shuttle™ automated manufacturing platform. The administration of an autologous cell therapy, which met all release criteria and was manufactured on

    4/14/26 4:30:00 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Root Insurance and Carvana Surpass 200,000 Policies Driven by Pioneering Embedded Insurance Partnership

    COLUMBUS, Ohio, April 14, 2026 (GLOBE NEWSWIRE) -- Root (NASDAQ:ROOT), the leading technology company in car insurance, and Carvana (NYSE:CVNA), the industry pioneer for buying and selling cars online, today announced that their exclusive embedded partnership, Carvana Insurance Built with Root, has surpassed 200,000 policies sold. This success underscores the power of the industry's first deep technical integration between a national car retailer and a digital-first insurer. Root is the exclusive embedded insurance provider for Carvana customers in the 36 states where Root currently offers car insurance. Carvana Insurance Built with Root powers a seamless, fully integrated experience th

    4/14/26 9:00:00 AM ET
    $CVNA
    $ROOT
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Property-Casualty Insurers
    Finance

    $ABT
    $ASML
    $AYLA
    $CABA
    SEC Filings

    View All

    SEC Form 144 filed by The Vita Coco Company Inc.

    144 - Vita Coco Company, Inc. (0001482981) (Subject)

    4/14/26 1:33:02 PM ET
    $COCO
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 6-K filed by Redhill Biopharma Ltd.

    6-K - RedHill Biopharma Ltd. (0001553846) (Filer)

    4/14/26 7:00:07 AM ET
    $RDHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by The Vita Coco Company Inc.

    144 - Vita Coco Company, Inc. (0001482981) (Subject)

    4/13/26 4:17:23 PM ET
    $COCO
    Beverages (Production/Distribution)
    Consumer Staples

    $ABT
    $ASML
    $AYLA
    $CABA
    Leadership Updates

    Live Leadership Updates

    View All

    Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

    • Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer  VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced the full-time appointments of Dr. Adam Schayowitz and Mr. Scott Platshon as of April 9, 2026, from their previously interim roles. Both Dr. Schayowitz and Mr. Platshon will report directly to Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks. "These appointments come at a pivotal time for Zymeworks as we e

    4/9/26 6:00:00 AM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    It's 4/4, Time to Make a Wish: United & Make-A-Wish to Host 'Make More Wishes' Events Across Nation, Giving Wish Kids Behind-the-Scenes Access to Aviation

    Airline plans 2026 events on May 5 (5.5), June 6 (6.6), July 7 (7.7), August 8, (8.8), September 9 (9.9), October 10 (10.10), and November 11 (11.11)United honors 40 years of supporting Make-A-Wish as the airline celebrates its 100th anniversary with immersive experiences across hub airportsCHICAGO, April 4, 2026 /PRNewswire/ -- United Airlines and Make-A-Wish today announced the launch of "Make More Wishes," seven immersive events across the U.S. giving children fighting critical illnesses and their families behind-the-scenes access to all aspects of aviation. The immersive exp

    4/4/26 8:00:00 AM ET
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    United to Introduce Tiered Fare Categories, Giving Customers More Options Across Every Type of Ticket

    Airline to offer base, standard and flexible fare options for United Polaris® and United Premium Plus® customers traveling on long-haul international, transcontinental U.S. and select Hawaii flights, joining the existing basic, standard and flexible fares in United Economy® cabinsCustomers can select options related to seat selection, checked bags, refundable tickets, and club and lounge access that best meet their preferencesOn select transcontinental U.S. and select longer Hawaii flights, the front cabin will be branded United Polaris and will include options to access the United Polaris loungeUnited plans to roll out the new tiered fare categories this yearCHICAGO, April 3, 2026 /PRNewswi

    4/3/26 8:00:00 AM ET
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    $ABT
    $ASML
    $AYLA
    $CABA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Director Orthwein Peter Busch bought $229,450 worth of shares (2,600 units at $88.25) (SEC Form 4)

    4 - THOR INDUSTRIES INC (0000730263) (Issuer)

    3/9/26 8:44:28 PM ET
    $THO
    Homebuilding
    Industrials

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ABT
    $ASML
    $AYLA
    $CABA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 4:50:19 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABT
    $ASML
    $AYLA
    $CABA
    Financials

    Live finance-specific insights

    View All

    ASML reports €8.8 billion total net sales and €2.8 billion net income in Q1 2026

    ASML reports €8.8 billion total net sales and €2.8 billion net income in Q1 2026ASML now expects 2026 total net sales to be between €36 billion and €40 billion, with a gross margin between 51% and 53% VELDHOVEN, the Netherlands, April 15, 2026 – Today, ASML Holding NV (ASML) has published its 2026 first-quarter results.   Q1 total net sales of €8.8 billion, gross margin of 53.0%, net income of €2.8 billionASML expects Q2 2026 total net sales between €8.4 billion and €9.0 billion, and a gross margin between 51% and 52%ASML now expects 2026 total net sales to be between €36 billion and €40 billion, with a gross margin between 51% and 53% (Figures in millions of euros unless otherwise indicat

    4/15/26 1:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    United to Hold Webcast of First-Quarter 2026 Financial Results

    CHICAGO, April 1, 2026 /PRNewswire/ -- United will hold a conference call to discuss first-quarter 2026 financial results on Wednesday, April 22 at 9:30 a.m. CT/10:30 a.m. ET.A live, listen-only webcast of the conference call will be available at ir.united.com. The company will issue its first-quarter results and outlook after market close on Tuesday, April 21.About UnitedAt United, Good Leads The Way. With U.S. hubs in Chicago, Denver, Houston, Los Angeles, New York/Newark, San Francisco and Washington, D.C., United operates the most comprehensive global route network among North American carriers, and is now the largest airline in the world as measured by available seat miles. For more abo

    4/1/26 10:00:00 AM ET
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    Carvana to Report First Quarter 2026 Results and Host Quarterly Conference Call on April 29

    Carvana (NYSE:CVNA), the industry pioneer for buying and selling cars online, today announced it will report its first quarter 2026 financial results for the period ended March 31, 2026, after the market closes on Wednesday, April 29, 2026. On that day, management will hold a conference call and webcast at 5:30 p.m. ET (2:30 p.m. PT) to review and discuss the company's business and results. What:   Carvana First Quarter 2026 Financial Results Conference Call When:   Wednesday, April 29, 2026 Time:   5:30 p.m. ET (2:30 p.m. PT) Live Call:   (833) 255-2830 or (412) 902-6715 An archived webcast of the conference call will be accessible

    4/1/26 9:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary